Pioneering red light-activated anti-tumor prodrug reduces side effects

Phorbiplatin is a new anti-cancer prodrug that can be controllably activated by red light. With its unique 'on-site' activation characteristic, this new prodrug can effectively kill cancer cells and minimize damage to normal tissues.